cis(+/-)-3-(tert-Butoxycarbonyl)amino-1-(diphenylmethyl)-2-ethylazetidine → cis(+/-)-3-(tert-Butoxycarbonyl)amino-2-ethylazetidine
反応式
[C:1]([O:5][C:6]([NH:8][C@H:9]1[CH2:12][N:11](C(C2C=CC=CC=2)C2C=CC=CC=2)[C@H:10]1[CH2:26][CH3:27])=[O:7])([CH3:4])([CH3:3])[CH3:2]>[Pd]>[C:1]([O:5][C:6]([NH:8][C@H:9]1[CH2:12][NH:11][C@H:10]1[CH2:26][CH3:27])=[O:7])([CH3:4])([CH3:3])[CH3:2]参加物
3
実験手順
The same operation as in Example (234e) was performed using cis(±)-3-(tert-butoxycarbonyl)amino-1-(diphenylmethyl)-2-ethylazetidine obtained in Example (235e) (154 mg, 0.42 mmol) and 10% Pd/C (30 mg), to obtain 66 mg of the title compound as a white solid (79%).
出典と根拠
- ORDレコード
- ord-177e7e3a0665403b873de4cd572fc87b
- 出典データセット
- uspto-grants-2015_01
- 特許番号
- US08927588B2
反応ノート
読み込み中…